{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:25:00Z","timestamp":1783434300241,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.prp.2022.153804","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:43:46Z","timestamp":1644972226000},"page":"153804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma"],"prefix":"10.1016","volume":"231","author":[{"given":"Pasquale","family":"Cretella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Lucia","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Picariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Puzziello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Sabbatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pio","family":"Zeppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2022.153804_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"303","author":"Swerdlow","year":"2017"},{"issue":"20","key":"10.1016\/j.prp.2022.153804_bib2","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.prp.2022.153804_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/ijd.IJD_74_17","article-title":"A literature revision in primary cutaneous B-cell lymphoma","volume":"62","author":"La Selva","year":"2017","journal-title":"Indian J. Dermatol."},{"issue":"5","key":"10.1016\/j.prp.2022.153804_bib4","first-page":"368","article-title":"Primary cutaneous lymphomas: diagnosis and treatment","volume":"32","author":"Soko\u0142owska-Wojdy\u0142o","year":"2015","journal-title":"Post. Derm. Alergol."},{"issue":"18","key":"10.1016\/j.prp.2022.153804_bib5","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1182\/blood-2010-12-322362","article-title":"Gene-expression profiling and not immunophenotypic algorithms predicts prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy","volume":"117","author":"Gutierrez-Garc\u00eda","year":"2011","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.prp.2022.153804_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"Scott","year":"2014","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.prp.2022.153804_bib7","doi-asserted-by":"crossref","first-page":"22014","DOI":"10.18632\/oncotarget.15782","article-title":"Cell-of-origin of diffuse large B-cell lymphomas determined by the Lymph2Cx assay: better prognostic indicator than Hans algorithm","volume":"8","author":"Yoon","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.prp.2022.153804_bib8","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2022.153804_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1523-1747.2003.12142.x","article-title":"Gene expression profiles of cutaneous B cell lymphoma","volume":"120","author":"Storz","year":"2003","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.prp.2022.153804_bib10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1309\/AJCPV3F9BEFCTAOQ","article-title":"Primary cutaneous follicle center lymphoma associated with an extracutaneous dissemination a cytogenetic finding of potential prognostic value","volume":"144","author":"Subramaniyam","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2022.153804_bib11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1634\/theoncologist.2015-0175","article-title":"Primary cutaneous B-cell lymphoma: management and patterns of recurrence at the multimodality cutaneous lymphoma clinic of the ohio state university","volume":"20","author":"Haverkos","year":"2015","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.prp.2022.153804_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1590\/abd1806-4841.20153638","article-title":"Cutaneous primary B-cell lymphomas: from diagnosis to treatment","volume":"90","author":"Lima","year":"2015","journal-title":"Bras. Dermatol."},{"issue":"Suppl. 4","key":"10.1016\/j.prp.2022.153804_bib13","doi-asserted-by":"crossref","first-page":"iv30","DOI":"10.1093\/annonc\/mdy133","article-title":"Primary cutaneous lymphomas: ESMO clinical practice guidelines","volume":"29","author":"Willemze","year":"2018","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2022.153804_bib14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/cyt.12132","article-title":"Fine needle aspiration cytology of lymphoproliferative lesions of the oral cavity","volume":"25","author":"Cozzolino","year":"2014","journal-title":"Cytopathology"},{"key":"10.1016\/j.prp.2022.153804_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/cncy.21626","article-title":"CD10, BCL6, and MUM1 expression in diffuse large B-Cell lymphoma on FNA samples","volume":"124","author":"Cozzolino","year":"2016","journal-title":"Cancer (Cancer Cytopathol. )"},{"key":"10.1016\/j.prp.2022.153804_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2407-14-8","article-title":"Lymph node fine needle cytology in the staging and follow-up of cutaneous lymphomas","volume":"14","author":"Vigliar","year":"2014","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.prp.2022.153804_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2022.153804_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","article-title":"Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma","volume":"101","author":"Colomo","year":"2003","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.prp.2022.153804_bib19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/path.1924","article-title":"Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma","volume":"208","author":"Muris","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2022.153804_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1182\/blood.V99.3.856","article-title":"Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma","volume":"99","author":"Rambaldi","year":"2002","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.prp.2022.153804_bib21","doi-asserted-by":"crossref","first-page":"18036","DOI":"10.18632\/oncotarget.7495","article-title":"Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB\/non-GCB by immunohistochemistry is still a robust and feasible marker","volume":"7","author":"Batlle-L\u00f3pez","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.prp.2022.153804_bib22","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/jid.2015.27","article-title":"The high expression of the microRNA 17-92 cluster and its paralogs, and the downregulation of the target gene PTEN, is associated with primary cutaneous B-cell lymphoma progression","volume":"135","author":"Battistella","year":"2015","journal-title":"J. Invest Dermatol."},{"issue":"4","key":"10.1016\/j.prp.2022.153804_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00000478-200604000-00015","article-title":"Molecular cytogenetic evidence of t(14;18)(IGH;BCL2) in a substantial proportion of primary cutaneous follicle center lymphomas","volume":"30","author":"Berthold","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"issue":"2","key":"10.1016\/j.prp.2022.153804_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2022.153804_bib25","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jaad.2006.12.026","article-title":"New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas","volume":"56","author":"Hallermann","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2022.153804_bib26","first-page":"124","article-title":"Comparison of two different immunohistochemical algorithms identifying prognostic subgroups of DLBCL","volume":"61","author":"Jab\u0142o\u0144ska","year":"2010","journal-title":"Pol. J. Pathol."},{"issue":"9","key":"10.1016\/j.prp.2022.153804_bib27","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.jid.2017.06.013","article-title":"Novel mutations involving NF- \u03baB and B-cell signaling pathways in primary cutaneous large B-cell lymphoma, leg-type and comparison with s\u00e9zary syndrome","volume":"137","author":"Kim","year":"2017","journal-title":"J. Invest Dermatol."},{"issue":"12","key":"10.1016\/j.prp.2022.153804_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082471","article-title":"MicroRNA profiling of primary cutaneous large B-cell lymphomas","volume":"8","author":"Koens","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.prp.2022.153804_bib29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/gcc.10104","article-title":"Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis","volume":"35","author":"Mao","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.prp.2022.153804_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab","volume":"29","author":"Meyer","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2022.153804_bib31","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","article-title":"MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"132","author":"Pham-Ledard","year":"2012","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.prp.2022.153804_bib32","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.prp.2022.153804_bib33","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.0303-6987.2005.00298.x","article-title":"Expression of the bcl-6 and MUM1\/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study","volume":"32","author":"Sundram","year":"2005","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.prp.2022.153804_bib34","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1732008100","article-title":"A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B-cell lymphoma","volume":"100","author":"Wright","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.prp.2022.153804_bib35","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/cam4.650","article-title":"Machine learning-based classification of diffuse large B-cell lymphoma patients by eight gene expression profiles","volume":"5","author":"Zhao","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2022.153804_bib36","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1002\/cncr.27396","article-title":"Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab","volume":"118","author":"Akyurek","year":"2012","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.prp.2022.153804_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjh.14812","article-title":"Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents","volume":"179","author":"Szczepanowski","year":"2017","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.prp.2022.153804_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/path.2374","article-title":"Profiling of apoptosis genes identifies distinct types of primary cutaneous large B cell lymphoma","volume":"215","author":"van Galen","year":"2008","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2022.153804_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","article-title":"Absence of the t(14;18) chromosomal translocation in primary cutaneous B\u2010cell lymphoma","volume":"144","author":"Child","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.prp.2022.153804_bib40","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:50:33Z","timestamp":1759733433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":40,"alternative-id":["S0344033822000474"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153804","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunohistochemical algorithms and gene expression profiling in primary cutaneous B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153804"}}